RP11–79H23.3 suppresses the pathogenesis and development of the bladder cancer, acting as competing endogenous RNA to increase the phosphatase and tensin homolog (PTEN) expression [38,39]. This evidence concerns the gene PTEN and urinary bladder carcinoma.